$ADIL· SEC filing ·

ADIL Reports $0 Revenue, -$12.3M Net Loss, +15% IP Patents, Molteni Europe Deal

Adial Pharmaceuticals, Inc · PHARMACEUTICAL PREPARATIONS · Now $2.45

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS